Phase 2 Trial of Gene Therapy, VY-AADC02, for Advanced Parkinson’s Enrolling in US
The trial will assess VY-AADC02, a gene therapy for Parkinson's patients diagnosed 4 or more years ago and with motor fluctations, against a sham surgery.
1 Comment